Article Versions Notes

Rozendal P, Kievit H, van der Leest P, Bahce I, Pegtel M, Groen HJM, van Kempen LC, Hiltermann TJN, Schuuring E. Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors—An Explorative Study. International Journal of Molecular Sciences. 2025; 26(16):8087. https://doi.org/10.3390/ijms26168087

Rozendal, Pim, Hanneke Kievit, Paul van der Leest, Idris Bahce, Michiel Pegtel, Harry J. M. Groen, Léon C. van Kempen, T. Jeroen N. Hiltermann, and Ed Schuuring. 2025. "Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors—An Explorative Study" International Journal of Molecular Sciences 26, no. 16: 8087. https://doi.org/10.3390/ijms26168087

Rozendal, P., Kievit, H., van der Leest, P., Bahce, I., Pegtel, M., Groen, H. J. M., van Kempen, L. C., Hiltermann, T. J. N., & Schuuring, E. (2025). Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors—An Explorative Study. International Journal of Molecular Sciences, 26(16), 8087. https://doi.org/10.3390/ijms26168087